{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"Krista Brown: ATM Mutation, Delayed Diagnosis, and What Self-Advocacy Actually Costs","description":" Guest: Krista (Oncology Nurse Navigator) Theme: Self-Advocacy, ATM Mutation, Cancer After Previvorhood   EPISODE SUMMARY When Krista's mother was 48, she became the first known cancer diagnosis in their family. She tested negative for BRCA mutations and felt relief \u2014 relief that she wouldn't pass anything on to her children. Twelve years later, just before entering hospice, she was offered expanded genetic testing and found out she carried a pathogenic ATM variant. She shared those results with her children. A few months after her death, Krista \u2014 38 years old, a nurse, carrying twelve years of hospital vigils and treatment complications in her body \u2014 went in and requested her own testing. What unfolds from that appointment is a story about what it actually takes to move through a healthcare system that doesn't know your mutation, that tells you the abnormality on your MRI is a lymph node, that sends you home with "come back in six months." Krista pushed for a biopsy that three specialists told her she didn't need. She was right. Her cancer diagnosis arrived two weeks before her scheduled preventive surgery. She now works as an oncology nurse navigator, walks patients through the same system she had to fight, and has built an educational platform for the hereditary cancer community \u2014 shaped entirely by what she wasn't told when she needed it most. WE COVER Testing too late, too little: Why Krista \u2014 a nurse with two generations of breast cancer in her family \u2014 was never offered genetic testing for twelve years, and what that delay meant for her outcomes. The self-advocacy paradox: The tension of knowing something is wrong, having a medical background, identifying as a people-pleaser, and still having to push three specialists who said she was overreacting. ATM mutation specifics: What carriers of ATM pathogenic variants actually face \u2014 including a 69% breast cancer risk, pancreatic and ovarian risk, and why the focus on BRCA leaves ATM carriers navigating without a map. The middle phase nobody prepares you for: The psychological and bodily experience of bilateral mastectomy with flap reconstruction between the first and second surgery \u2014 including what it does to a woman's relationship with her own reflection. Explaining hereditary cancer to children: How Krista told her daughters (ages 5, 8, and 10 at diagnosis) about her mutation, her surgery, and later her cancer \u2014 including what she had to process in herself first before she could speak from a calm place. The grief that doesn't announce itself: How choosing surgery \u2014 a choice she felt grateful for \u2014 still produced grief she felt she wasn't allowed to have, and why "I chose this" doesn't close off mourning. Cancer as identity reorganizer: How the experience shifted what Krista allows into her life, where she places her attention, and what felt insufficient about who she'd been before this began. What the oncology system still misses: How even inside treatment, secondary risks (pancreatic, ovarian) get dropped after the primary intervention, and why mutation carriers need to track their full risk profile across specialties. HIGHLIGHTS & TAKEAWAYS Three specialists told her the abnormality wasn't cancer. She pushed anyway. That instinct \u2014 the unsettled feeling she couldn't explain \u2014 was the most accurate clinical information she had. Learning to trust it required overriding the authority gradient we're all trained to defer to. The grief of choosing surgery is still grief. Knowing you're lucky, knowing you have options, knowing what you avoided \u2014 none of that neutralizes what it costs to look in the mirror at a body mid-reconstruction and not recognize yourself. Gratitude and loss occupy the same moment. What she modeled for her daughters wasn't resilience. It was legibility \u2014 making the emotional experience visible and speakable so it could move through them instead of getting stored somewhere unnamed. The shift from previvor to cancer diagnosis didn't happen at diagnosis. It had been accumulating across twelve years of watching her mother, then across the months of self-advocacy, then across a two-week window between a positive biopsy and surgery already on the calendar. The "before and after" is rarely a single moment. She found her way into the hereditary cancer community not as someone who sought support, but as someone who had always been "fine." The connection she found there changed more than her career \u2014 it changed what she understood about what she'd actually needed all along. CONTENT NOTE This episode includes detailed discussion of a parent's cancer diagnosis and death, including end-of-life care and hospice. Krista also shares her own cancer diagnosis and surgical experience, including the psychological impact of bilateral mastectomy with reconstruction. The conversation includes reference to the loss of a sister-in-law to cancer at age 38. RESOURCES MENTIONED Guest resources: Krista on Instagram: @cancer.prevention.coach \u2014 hereditary cancer education and advocacy content for the ATM and broader high-risk community Standard links: Face the Risk Together support groups: sarachampielcsw.com FORCE (Facing Our Risk of Cancer Empowered): facingourrisk.org \u2014 national organization for hereditary cancer advocacy and peer support National Society of Genetic Counselors (NSGC): nsgc.org \u2014 find a certified genetic counselor for hereditary cancer risk CONNECT If this conversation resonates, follow, rate, and share the show. Find Sara Champie on IG @sarachampielcsw and sarachampielcsw.com for free resources and access to 1:1 and group support. You already speak this language \u2014 come walk the genetic line with us. Sara Champie ","author_name":"Walking the Genetic Line","author_url":"https:\/\/sites.libsyn.com\/584990","html":"